プログラム委員会
-
Shinzo Hiroi, PHD, MPH, RPH, PMP Senior Director, Project Management, IDC ICO Real World Solutions
ICON Clinical Research GK, Japan -
Kentaro Kogushi, PHD Head of Clinical Development Neurology-Psychiatry, Japan Development
AbbVie GK, Japan -
Yusuke Nakamura, MBA, MPH Pharmaceuticals Division, Market Acccess
Bayer Yakuhin, Ltd., Japan -
Shinya Ohno, PHD, MPH Director, HTA Strategy Professional
Chugai Pharmaceutical Co., Ltd, Japan -
Masayo Sato
Eli Lilly Japan K.K., Japan -
Akihito Uda, MPH Health Economics & Outcome Reserch, Value & Access Division
Novartis Pharma K.K., Japan -
Hisashi Urushihara, DrPH Professor, Faculty of Pharmacy, Department of Pharmacy
Keio University, Japan -
Manami Yoshida, DVM Associate Director, Medical Affairs – HIV & COVID-19
Gilead Sciences K.K., Japan -
Hiroyuki Sakamaki, DRSC, PHD, MBA Professor, School of Health Innovation
Kanagawa University of Human Services, Japan -
Kuniko Shoji Vice-Dean, School of Health Innovation
Kanagawa University of Human Services, Japan
